NEW YORK (GenomeWeb) – Australia's SA Pathology has received National Association of Testing Authorities accreditation to perform whole-exome sequencing services.
The firm said its genetics and molecular pathology laboratory, in collaboration with the Centre for Cancer Biology (CCB) and the University of South Australia, is the first facility in Australia to receive accreditation for whole-exome sequencing services. The lab has also received accreditation for next-generation sequencing gene panels targeting disease.
NATA accreditation is comparable to CLIA or CAP certification in the US, Hamish Scott, director of CCB's Australian Cancer Research Foundation (ACRF), told GenomeWeb in an email.
SA Pathology said in a statement that it is now rolling out whole-exome sequencing for clinical use in partnership with the University of Adelaide, the ACRF, Therapeutic Innovation Australia, and eResearchSA.